Irreversible CYP3A inhibition accompanied by plasma protein-binding displacement: a comparative analysis in subjects with normal and impaired liver function.
about
Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactamsPharmacokinetic drug interactions in liver disease: An updateSevere liver cirrhosis markedly reduces AhR-mediated induction of cytochrome P450 in rats by decreasing the transcription of target genes.Darunavir and ritonavir total and unbound plasmatic concentrations in HIV-HCV-coinfected patients with hepatic cirrhosis compared to those in HIV-monoinfected patientsApplication of mechanism-based CYP inhibition for predicting drug-drug interactions.Preliminary study of quinine pharmacokinetics in pregnant women with malaria-HIV co-infection.The effect of liver disease on inhibitory and plasma protein-binding displacement interactions: an update.Do children have the same vulnerability to metabolic drug–drug interactions as adults? A critical analysis of the literature.Effects of ritonavir-boosted lopinavir on the pharmacokinetics of quinine.
P2860
Q24631021-BC7FB883-19E1-4E12-9765-14C75F64729BQ26774479-EB4FFBA5-5E0F-434A-93C1-D03188F87679Q34692592-80C97B44-FAFB-4F21-BCA3-AE44157F7777Q36158135-132BFE5D-B5C2-4130-A1C5-3C9A90F35661Q37494640-5B3BE4E3-E0C1-43AD-84FC-566922B648FAQ37623297-5F93E16B-4BB6-44B6-B4FE-58EF1259BCBCQ37770251-70FE12C7-353E-42CC-899F-DF47040DD880Q38110809-4636932E-4301-45AD-A6A3-ADBC59E5DE2DQ48006398-D01CCC15-F86C-41F2-B558-810EA22290E9
P2860
Irreversible CYP3A inhibition accompanied by plasma protein-binding displacement: a comparative analysis in subjects with normal and impaired liver function.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Irreversible CYP3A inhibition ...... l and impaired liver function.
@en
Irreversible CYP3A inhibition ...... l and impaired liver function.
@nl
type
label
Irreversible CYP3A inhibition ...... l and impaired liver function.
@en
Irreversible CYP3A inhibition ...... l and impaired liver function.
@nl
prefLabel
Irreversible CYP3A inhibition ...... l and impaired liver function.
@en
Irreversible CYP3A inhibition ...... l and impaired liver function.
@nl
P2093
P2860
P356
P1476
Irreversible CYP3A inhibition ...... al and impaired liver function
@en
P2093
P2860
P304
P356
10.1038/CLPT.2008.216
P407
P577
2008-11-19T00:00:00Z